Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sze Pui Tsui"'
Autor:
Dandan Wang, Lichuan Zheng, Bowie Yik Ling Cheng, Chun-Fung Sin, Runsheng Li, Sze Pui Tsui, Xinyu Yi, Alvin Chun Hang Ma, Bai Liang He, Anskar Yu Hung Leung, Xuan Sun
Publikováno v:
Oncogene. 42:1272-1281
Isocitrate dehydrogenase 2 (IDH2) mutations occur in more than 15% of cytogenetically normal acute myeloid leukemia (CN-AML) but comparative studies of their roles in leukemogenesis have been scarce. We generated zebrafish models of IDH2R172K and IDH
Autor:
Dandan Wang, Lichuan Zheng, Bowie Yik Ling Cheng, Chun-Fung Sin, Runsheng Li, Sze Pui Tsui, Xinyu Yi, Alvin Chun Hang Ma, Bai Liang He, Anskar Yu Hung Leung, Xuan Sun
Publikováno v:
Oncogene. 42:1331-1331
Autor:
Yanan Chen, Sin Chun-Fung, Lingge Tu, Hoi Yi Chan, Fangfang He, Dandan Wang, Sze Pui Tsui, Alvin Chun Hang Ma, Xuan Sun, Anskar Leung
Publikováno v:
Blood. 140:11491-11491
Autor:
Lingge Tu, SIN Chun-fung, Yanan Chen, Fangfang He, Dandan Wang, Hoi Yi Chan, Sze Pui Tsui, Alvin Chun Hang Ma, Xuan Sun, Anskar Leung
Publikováno v:
Blood. 140:11493-11493
Autor:
Sze‐Pui Tsui, Ning Yang, T. K. Chan, Wa Li, Ho-Wan Ip, Chun Hang Au, Stephen S. Y. Lam, Sze-Fai Yip, Chunxiao Zhang, Yok-Lam Kwong, Nelson K. L. Ng, Edmond S. K. Ma, June S. M. Lau, Anskar Y.H. Leung, Harold K. K. Lee, Tsan-Hei Luk, Garret M. K. Leung
Publikováno v:
CancerReferences. 126(2)
Background Omacetaxine mepesuccinate (OME) has antileukemic effects against acute myeloid leukemia (AML) carrying an internal tandem duplication of Fms-like tyrosine kinase 3 (FLT3-ITD). A phase 2 clinical trial was conducted to evaluate a combinatio
Autor:
Qing Liu, Christopher Chan, Chunxiao Zhang, Sze Pui Tsui, Ho-Wan Ip, Garret M. K. Leung, Harold K. K. Lee, Anskar Y.H. Leung, Thomas Wing Yan Leung, Bonnie Kho, Yok-Lam Kwong, Chun Hang Au, Sze Fai Yip, Edmond S. K. Ma, Ka Lam Nelson Ng
Publikováno v:
Blood. 134:3825-3825
Objectives: Acute myeloid leukemia (AML) carrying internal tandem duplication (ITD) of Fms-Like Tyrosine Kinase 3 (FLT3) is associated with high relapse risk and adverse outcome. This single-arm, phase 2 study evaluated efficacy and safety of combina
Autor:
Asif Javed, Sy Lin, Arthur Kwok Leung Cheung, Chi Ho Lin, Tsan-Hei Luk, Kelvin Ck Cheng, Chi Kuen Lau, Anskar Y.H. Leung, Suet Yi Leung, Bonnie Kho, Edmond S. K. Ma, Jason C. C. So, Sze Pui Tsui, Lisa L. P. Siu, Grace H W Cheng, Szeman June Lau, Harold K. K. Lee, Chunxiao Zhang, Kit Fai Wong, Tommy Ch Au, Sze Fai Yip, Ip Hw Alvin, Tommy W.F. Tang, Yok-Lam Kwong, Christopher Chan, Margaret H.L. Ng
Publikováno v:
Blood. 134:1400-1400
Background. Cytogenetically normal acute myeloid leukaemia (CN-AML) occurs in 50% adult AML and is a group of diseases with diverse mutations and distinct clinical outcome. CEBPα, NPM1 and FLT3 mutations that are commonly seen in CN-AML have been in
Autor:
Tommy W.F. Tang, Anskar Y.H. Leung, Chi Kuen Lau, Sze Fai Yip, Bonnie Kho, Kelvin C K Cheng, Edmond S. K. Ma, Tsan-Hei Luk, Jason C. C. So, Chun Hang Au, Kit Fai Wong, Christopher Chan, Sy Lin, Yok-Lam Kwong, Lisa L. P. Siu, Harold K. K. Lee, Szeman June Lau, Chunxiao Zhang, Ho-Wan Ip, Margaret H.L. Ng, Sze Pui Tsui
Publikováno v:
Blood. 132:5267-5267
Background. Acute myeloid leukaemia (AML) is a group of heterogeneous diseases with distinct clinicopathologic, cytogenetic and genetic features, sharing in common an abnormal increase in myeloblasts in blood or bone marrow (BM). Induction and consol